Back to search

Article

Literature analysis of Cadonilimab-induced adverse drug reaction

2025-04-15

Abstract excerpt

This systematic review characterizes adverse drug reactions (ADRs) associated with cadonilimab (AK104), a bispecific immune checkpoint inhibitor, to inform clinical safety protocols. We conducted a comprehensive literature search across PubMed, Web of Science, and Chinese databases (CNKI, Wanfang Data, VIP Network), identifying 16 case studies involving 22 patients (11 male, 11 female; age range: 34–81 years). Ger...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1923ae45-fc07-5cce-9e30-6ddb4d8908fc
DOI
10.22541/au.174470060.01355990/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Literature analysis of Cadonilimab-induced adverse drug reactionDOI 10.22541/au.174470060.01355990/v1
Real-World Data Analysis of Vascular and Lymphatic Adverse Events Associated with Anti-Tumor Angiogenesis Drugs: A WHO-VigiAccess StudySemantic proximity
Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.Semantic proximity
Cutaneous immune-related adverse events are associated with longer overall survival in advanced cancer patients on immune checkpoint inhibitors: a multi-institutional cohort studySemantic proximity
Biologic Treatment for Cutaneous Immune-Related Adverse Events in Cancer Patients Undergoing Immune-Checkpoint Therapy: A Retrospective ReviewSemantic proximity
Distinct Adverse Event Profiles of Eight Chemotherapeutic Agents: A FAERS Database Analysis Focusing on Peripheral NeuropathySemantic proximity
Research progress on mechanisms and predictive biomarkers for immune-related adverse eventsSemantic proximity
Adverse event profile differences between Trastuzumab Emtansine and Trastuzumab Deruxtecan: a real-world, pharmacovigilance studySemantic proximity
Common Causes and Characteristics of Adverse Drug Reactions in Older Adults: A Retrospective StudySemantic proximity
Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort StudySemantic proximity
Hepatic Failure Associated with Immune Checkpoint Inhibitors: A Real-world Study from the Food and Drug Administration Adverse Event Reporting System (FAERS) DatabaseSemantic proximity
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse eventsSemantic proximity
Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.Semantic proximity
Select a neighboring publication to make it the new centre.